Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Buys Biopharmaceutical Product Manufacturer MMB

NEW YORK (GenomeWeb News) - Sigma-Aldrich has acquired the biopharmaceutical contract manufacturer Molecular Medicine BioServices for an undisclosed amount of cash, Sigma said yesterday.
Sigma said it bought the Carlsbad, Calif.-based MMB to expand its SAFC Pharma business segment.
Sigma said MMB’s $12 million in annualized revenues will help it reach its growth goals, but will have a neutral impact on earnings in 2007.
MMB develops and manufactures viral products and offers DNA, RNA, and active ingredients for the production of novel vaccines and gene therapies. The company has 60 employees, a 23,700-square-foot lab and headquarters, and a 21,400-square-foot manufacturing facility.
Sigma said it plans to retain all of MMB's existing management and employees.
Sigma’s SAFC segment focuses on high-purity inorganics, cell culture products, and other services.
SAFC president Frank Wicks said the addition of MMB gives the company "critical capability" to produce viruses, and will complement the company's transgenic extraction and purification facility in St. Louis and a bacterial fermentation lab it is building in Israel.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.